The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. It is located in central Houston in the Texas Medical Center. MD Anderson provides cancer care at several locations throughout the Greater Houston Area and collaborates with health systems nationwide through MD Anderson Cancer Network®.
MD Anderson was created in 1941 as part of The University of Texas System. The institution is one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of 51 National Cancer Institute-designated comprehensive cancer centers today.
U.S. News & World Report's "Best Hospitals" survey has ranked MD Anderson the nation's top hospital for cancer care. The institution has been named one of the nation's top two hospitals for cancer care every year since the survey began in 1990.
Since 1944, almost 1.8 million people have turned to MD Anderson for cancer care.
MD Anderson pathologists change a new patient's initial diagnosis by another institution up to 25% of the time and cancer staging up to 38% of the time.
MD Anderson's world-renowned physicians are extensively trained specialists who focus on one type of cancer and one aspect of treatment, giving them unrivaled expertise. 100% of MD Anderson's surgeons are trained in oncology compared to 30% in community hospitals.
FY21 Patient Care Facts
- MD Anderson cared for more than 174,126 patients
- Nearly 9,700 patients were enrolled in 1,600 clinical trials exploring innovative treatments.
- MD Anderson provided uninsured or underinsured Texans more than $314 million in uncompensated care.
- More than 22,000 employees, including 1,825 faculty
- 1,357 myCancerConnection volunteers
MD Anderson boasts one of the nation's most esteemed faculties.
Among the institution's educators are:
- 1 Nobel Laureate
- 8 National Academy of Medicine members
- 6 National Academy of Sciences members
- 6 Academy of Arts and Sciences members
- 48 American Association for the Advancement of Science fellows
- 12 Association of American Physicians members
- 27 American Society of Clinical Investigation members
In FY 2021, more than 4,800 trainees participated in MD Anderson educational programs. This included:
- 1,687 clinical residents and fellows
- 576 nursing trainees
- 378 School of Health Professions students
- 1,364 research trainees
- 798 student program participants
- 43 interns and fellows participated in special programs
Research at MD Anderson
At MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated to clinical care. In FY 2021, MD Anderson invested more than $1 billion in research.
MD Anderson is home to one of the world's largest cancer clinical trials programs, providing patients with access to life-saving investigational drugs before they are approved by the Food and Drug Administration (FDA). In FY21, 29 drugs tested here received FDA approval.
195 patents were awarded to MD Anderson in FY21.
MD Anderson receives millions of dollars in grant funding from the Cancer Prevention Research Institute of Texas (CPRIT) for research, prevention, recruitment and training. MD Anderson received more than $32 million in funding from CPRIT in FY21.
MD Anderson holds nine National Cancer Institute Specialized Programs of Research Excellence (SPORE) grants in endometrial, prostate, melanoma, gastrointestinal, brain, leukemia, lung, ovarian and hepatocellular cancers.
Commitment to Cancer Prevention
Cancer prevention plays a vital role in advancing MD Anderson's mission to end cancer.
In FY 2021:
- There were more than 34,500 patient visits to our Lyda Hill Cancer Prevention Center, which provides cancer screenings and risk-reduction services.
- 4,724 people received tobacco cessation services through our Tobacco Treatment Program.
- MD Anderson held 346 cancer prevention education programs in the community.